IPG Photonics Corporation $IPGP Shares Sold by UBS Group AG

UBS Group AG trimmed its holdings in IPG Photonics Corporation (NASDAQ:IPGP) by 15.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 76,792 shares of the semiconductor company’s stock after selling 14,280 shares during the period. UBS Group AG’s holdings in IPG Photonics were worth $5,498,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in IPGP. Versant Capital Management Inc grew its position in shares of IPG Photonics by 51.1% during the third quarter. Versant Capital Management Inc now owns 343 shares of the semiconductor company’s stock worth $27,000 after buying an additional 116 shares in the last quarter. Assetmark Inc. raised its holdings in IPG Photonics by 6.8% in the fourth quarter. Assetmark Inc. now owns 1,820 shares of the semiconductor company’s stock valued at $130,000 after acquiring an additional 116 shares in the last quarter. Allworth Financial LP boosted its stake in IPG Photonics by 10.2% during the 3rd quarter. Allworth Financial LP now owns 1,449 shares of the semiconductor company’s stock valued at $115,000 after acquiring an additional 134 shares during the last quarter. Ballast Asset Management LP grew its holdings in IPG Photonics by 0.6% during the 3rd quarter. Ballast Asset Management LP now owns 34,941 shares of the semiconductor company’s stock worth $2,767,000 after acquiring an additional 197 shares in the last quarter. Finally, Orion Porfolio Solutions LLC grew its holdings in IPG Photonics by 2.8% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 7,922 shares of the semiconductor company’s stock worth $544,000 after acquiring an additional 215 shares in the last quarter. 93.79% of the stock is currently owned by hedge funds and other institutional investors.

IPG Photonics Stock Up 6.7%

Shares of NASDAQ:IPGP opened at $120.91 on Thursday. The company has a market cap of $5.13 billion, a PE ratio of 175.23, a P/E/G ratio of 3.32 and a beta of 0.97. IPG Photonics Corporation has a fifty-two week low of $63.33 and a fifty-two week high of $155.82. The firm has a 50-day simple moving average of $115.45 and a 200 day simple moving average of $100.92.

IPG Photonics (NASDAQ:IPGP) last issued its earnings results on Tuesday, May 5th. The semiconductor company reported $0.29 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.03). The company had revenue of $265.50 million during the quarter, compared to analyst estimates of $256.99 million. IPG Photonics had a net margin of 2.78% and a return on equity of 2.84%. The business’s revenue was up 16.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.09 earnings per share. IPG Photonics has set its Q2 2026 guidance at 0.250-0.550 EPS. As a group, research analysts forecast that IPG Photonics Corporation will post 1.64 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on IPGP. Needham & Company LLC upgraded shares of IPG Photonics from a “hold” rating to a “buy” rating and set a $110.00 target price on the stock in a research note on Wednesday, May 6th. Citigroup boosted their price objective on IPG Photonics from $105.00 to $150.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Stifel Nicolaus cut their price objective on IPG Photonics from $165.00 to $125.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. Roth Mkm reaffirmed a “buy” rating and set a $151.00 target price on shares of IPG Photonics in a report on Tuesday. Finally, Raymond James Financial lowered IPG Photonics from a “strong-buy” rating to an “outperform” rating and lifted their target price for the stock from $97.00 to $180.00 in a research report on Friday, February 13th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $135.50.

Insider Buying and Selling

In other news, CAO Mary E. Buttarazzi sold 500 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $116.22, for a total transaction of $58,110.00. Following the completion of the transaction, the chief accounting officer owned 4,749 shares of the company’s stock, valued at approximately $551,928.78. The trade was a 9.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Jeanmarie F. Desmond sold 1,690 shares of the company’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $105.58, for a total transaction of $178,430.20. Following the transaction, the director owned 10,486 shares of the company’s stock, valued at $1,107,111.88. This represents a 13.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 37.50% of the company’s stock.

IPG Photonics Profile

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.